X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19132) 19132
Newsletter (5624) 5624
Newspaper Article (1747) 1747
Publication (1075) 1075
Magazine Article (656) 656
Transcript (319) 319
Book Review (128) 128
Trade Publication Article (108) 108
Dissertation (27) 27
Book / eBook (23) 23
Conference Proceeding (23) 23
Book Chapter (20) 20
Streaming Video (13) 13
Web Resource (10) 10
Government Document (5) 5
Data Set (4) 4
Reference (3) 3
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13365) 13365
anticholesteremic agents (13249) 13249
anticholesteremic agents - therapeutic use (8501) 8501
male (8418) 8418
cholesterol (7094) 7094
female (6377) 6377
middle aged (5230) 5230
index medicus (5183) 5183
animals (4752) 4752
anticholesteremic agents - pharmacology (4494) 4494
aged (3748) 3748
research (3565) 3565
hypercholesterolemia - drug therapy (3514) 3514
adult (3335) 3335
cholesterol - blood (3215) 3215
hypercholesterolemia (3145) 3145
cholesterol, ldl - blood (3113) 3113
risk factors (2986) 2986
anticholesteremic agents - administration & dosage (2520) 2520
low density lipoproteins (2501) 2501
statins (2405) 2405
atherosclerosis (2336) 2336
cardiovascular agents (2289) 2289
rats (2240) 2240
pharmacology & pharmacy (2200) 2200
cardiac & cardiovascular systems (2163) 2163
anticholesteremic agents - adverse effects (2031) 2031
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (2022) 2022
simvastatin (2018) 2018
treatment outcome (1988) 1988
reports (1811) 1811
medicine, general & internal (1783) 1783
drug therapy (1762) 1762
analysis (1743) 1743
pharmaceutical industry (1723) 1723
lipids (1681) 1681
prevention (1611) 1611
medical research (1607) 1607
care and treatment (1600) 1600
triglycerides - blood (1552) 1552
ezetimibe (1471) 1471
hypercholesterolemia - blood (1468) 1468
atorvastatin calcium (1449) 1449
medicine, experimental (1442) 1442
atorvastatin (1417) 1417
health aspects (1411) 1411
drug therapy, combination (1383) 1383
cholesterol, hdl - blood (1370) 1370
coronary heart disease (1265) 1265
lipids - blood (1248) 1248
pravastatin (1244) 1244
cholesterol - metabolism (1220) 1220
mice (1214) 1214
peripheral vascular disease (1182) 1182
physiological aspects (1147) 1147
risk (1144) 1144
coronary-heart-disease (1136) 1136
heptanoic acids - therapeutic use (1134) 1134
double-blind method (1128) 1128
cardiovascular diseases (1108) 1108
pyrroles - therapeutic use (1088) 1088
cardiovascular diseases - prevention & control (1083) 1083
biochemistry & molecular biology (1076) 1076
cardiovascular disease (1071) 1071
blood cholesterol (1059) 1059
diabetes (1047) 1047
simvastatin - therapeutic use (996) 996
hyperlipidemias - drug therapy (980) 980
coronary disease - prevention & control (948) 948
dose-response relationship, drug (948) 948
diet (932) 932
time factors (925) 925
liver - metabolism (913) 913
drugs (860) 860
antilipemic agents (859) 859
disease (853) 853
cardiology (844) 844
metabolism (835) 835
pravastatin - therapeutic use (828) 828
clinical trials as topic (818) 818
universities and colleges (815) 815
mortality (810) 810
clinical trials (805) 805
endocrinology & metabolism (798) 798
lipoproteins (794) 794
azetidines - therapeutic use (765) 765
nutrition & dietetics (763) 763
therapy (762) 762
cardiac patients (757) 757
hypercholesterolemia - complications (747) 747
liver - drug effects (733) 733
lovastatin - therapeutic use (731) 731
randomized controlled trials as topic (725) 725
cardiovascular (721) 721
cardiovascular-disease (711) 711
hypolipidemic agents - therapeutic use (709) 709
myocardial-infarction (706) 706
triglycerides (687) 687
aged, 80 and over (680) 680
efficacy (672) 672
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (12) 12
Online Resources - Online (10) 10
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Robarts - Stacks (1) 1
Royal Ontario Museum - Periodical Stacks (1) 1
UofT Schools - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (25456) 25456
German (485) 485
French (302) 302
Russian (211) 211
Spanish (186) 186
Italian (159) 159
Japanese (127) 127
Chinese (96) 96
Swedish (95) 95
Polish (80) 80
Norwegian (74) 74
Danish (73) 73
Dutch (66) 66
Hungarian (38) 38
Portuguese (36) 36
Czech (31) 31
Finnish (14) 14
Hebrew (10) 10
Romanian (9) 9
Turkish (7) 7
Ukrainian (6) 6
Croatian (4) 4
Lithuanian (3) 3
Bulgarian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pharmacological Research, ISSN 1043-6618, 05/2016, Volume 107, pp. 1 - 18
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 16, pp. 1517 - 1526
Journal Article
Journal Article
Journal of Cardiovascular Medicine, ISSN 1558-2027, 09/2018, Volume 19, Issue 9, pp. 485 - 490
AIMSThe analysis evaluated the contemporary percentage of patients with established coronary heart disease (CHD) reaching the European guidelines recommended... 
LDL-CHOLESTEROL | CARDIAC & CARDIOVASCULAR SYSTEMS | DYSLIPIDAEMIAS | METAANALYSIS | MANAGEMENT | proprotein convertase subtlisin/kexin type 9 inhibitors | HYPERCHOLESTEROLEMIA | THERAPY | ezetimibe | hydroxymethylglutaryl-CoA reductase inhibitors | STATIN | coronary heart disease | LDL cholesterol | CORONARY-HEART-DISEASE | CLINICAL-PRACTICE | ESC/EAS GUIDELINES | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Humans | Middle Aged | Coronary Disease - epidemiology | Male | Patient Selection | Dyslipidemias - blood | Serine Proteinase Inhibitors - adverse effects | Clinical Decision-Making | Aged, 80 and over | Cholesterol, LDL - blood | Female | Registries | Drug Therapy, Combination | Dyslipidemias - diagnosis | Coronary Disease - blood | Serine Proteinase Inhibitors - administration & dosage | Dyslipidemias - drug therapy | Risk Assessment | Administration, Oral | Ezetimibe - adverse effects | Down-Regulation | Risk Factors | Treatment Outcome | Ezetimibe - administration & dosage | Biomarkers - blood | Coronary Disease - diagnosis | Anticholesteremic Agents - adverse effects | Dyslipidemias - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Proprotein Convertase 9 - antagonists & inhibitors | Anticholesteremic Agents - administration & dosage | Coronary Disease - drug therapy | Italy - epidemiology | Aged
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 08/2007, Volume 35, Issue 8, pp. 1308 - 1314
Hepatic uptake carriers of the organic anion-transporting peptide (OATP) family of solute carriers are more and more recognized as being involved in hepatic... 
RAT | SEVERE RHABDOMYOLYSIS | COMBINATION THERAPY | LIVER | PHARMACOLOGY & PHARMACY | CERIVASTATIN | HEPATIC-UPTAKE | TRANSPLANT RECIPIENTS | ROSUVASTATIN | POLYPEPTIDE | FAMILY | Organic Anion Transporters, Sodium-Independent - genetics | Fatty Acids, Monounsaturated - pharmacology | Cricetulus | Hypolipidemic Agents - metabolism | Hypoglycemic Agents - metabolism | Taurocholic Acid - metabolism | Humans | Hepatocytes - metabolism | Simvastatin - pharmacology | Organic Anion Transporters - metabolism | Chromans - metabolism | Hepatocytes - cytology | Indoles - metabolism | Organic Anion Transporters - genetics | Drug Interactions | Anticholesteremic Agents - metabolism | Chromans - pharmacology | Fatty Acids, Monounsaturated - metabolism | Organic Anion Transporters, Sodium-Independent - metabolism | Indoles - pharmacology | Biological Transport - drug effects | Thiazolidinediones - pharmacology | Hepatocytes - drug effects | Solute Carrier Organic Anion Transporter Family Member 1B3 | CHO Cells | Pravastatin - pharmacology | Recombinant Proteins - metabolism | Taurocholic Acid - pharmacology | Cell Line | Cricetinae | Pravastatin - metabolism | Simvastatin - metabolism | Gemfibrozil - pharmacokinetics | Gemfibrozil - pharmacology | Hypolipidemic Agents - pharmacology | Thiazolidinediones - metabolism | Hypoglycemic Agents - pharmacology | Animals | Estrone - analogs & derivatives | Estrone - metabolism | Protein Binding | Fatty Acids, Monounsaturated - pharmacokinetics | Indoles - pharmacokinetics | Kinetics | Solute Carrier Organic Anion Transporter Family Member 1b1 | Anticholesteremic Agents - pharmacology | Gemfibrozil - metabolism
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2012, Volume 7, Issue 12, pp. e53280 - e53280
Journal Article
Atherosclerosis, ISSN 0021-9150, 2008, Volume 204, Issue 2, pp. 476 - 482
Abstract Background Risk factors of cardiovascular disease such as lipid aberrations, hypertension, abdominal adiposity and elevations in systemic... 
Cardiovascular | Cardiovascular disease | Inflammation | Hyperlipidemia | Plant sterols | Omega-3 fatty acids | C-REACTIVE PROTEIN | MYOCARDIAL-INFARCTION | SUDDEN-DEATH | OMEGA-3-FATTY-ACIDS | RISK | PHYTOSTEROLS | CARDIOVASCULAR-DISEASE | PERIPHERAL VASCULAR DISEASE | FISH-OIL | CORONARY-HEART-DISEASE | DOCOSAHEXAENOIC ACIDS | Blood Pressure | Body Composition | Hyperlipidemias - blood | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Hypolipidemic Agents - blood | Capsules | Lipids - blood | Anti-Inflammatory Agents - therapeutic use | Cardiovascular Diseases - blood | Adult | Anti-Inflammatory Agents - administration & dosage | Female | Hyperlipidemias - diet therapy | Hyperlipidemias - physiopathology | Phytosterols - therapeutic use | Hyperlipidemias - complications | Fatty Acids, Omega-3 - administration & dosage | Cardiovascular Diseases - etiology | Cardiovascular Diseases - physiopathology | Double-Blind Method | Risk Assessment | Administration, Oral | Risk Factors | Inflammation Mediators - blood | Treatment Outcome | Anti-Inflammatory Agents - blood | Phytosterols - administration & dosage | Phytosterols - blood | Hypolipidemic Agents - administration & dosage | Fatty Acids, Omega-3 - therapeutic use | Fatty Acids, Omega-3 - blood | Aged | Hypolipidemic Agents - therapeutic use | Dietary Supplements | Hypertension | Unsaturated fatty acids | Anti-inflammatory drugs | Analysis | Phytosterols | Anticholesteremic agents | Atherosclerosis
Journal Article